Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) with PF-Pembrolizumab. (2025). Voprosy Onkologii, 70(6), 1096-1105. https://doi.org/10.37469/0507-3758-2024-70-6-1096-1105